Harvard Bioscience (HBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Sales | 25,448 | 26,958 | 25,893 | 27,854 | 25,137 |
| Cost of Goods | 14,006 | 14,680 | 14,132 | 15,806 | 13,838 |
| Gross Profit | 11,442 | 12,278 | 11,761 | 12,048 | 11,299 |
| Operating Expenses | 10,023 | 11,220 | 10,559 | 13,803 | 11,723 |
| Operating Income | 1,425 | 1,738 | 1,334 | -949 | 414 |
| Interest Expense | 239 | 248 | 265 | 304 | 276 |
| Other Income | -230 | -220 | -50 | -17 | -81 |
| Pre-tax Income | 956 | 1,270 | 1,019 | -1,270 | 57 |
| Income Tax | 323 | 248 | 300 | -1,014 | 105 |
| Net Income Continuous | 633 | 1,022 | 719 | -256 | -48 |
| Net Income Discontinuous | N/A | N/A | N/A | -501 | -935 |
| Net Income | $633 | $1,022 | $719 | $-757 | $-983 |
| EPS Basic Total Ops | 0.20 | 0.30 | 0.20 | -0.20 | -0.30 |
| EPS Basic Continuous Ops | 0.20 | 0.32 | 0.20 | -0.12 | -0.02 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | -0.10 | -0.30 |
| EPS Diluted Total Ops | 0.20 | 0.30 | 0.20 | -0.20 | -0.30 |
| EPS Diluted Continuous Ops | 0.19 | 0.31 | 0.20 | -0.11 | -0.02 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | -0.10 | -0.30 |
| EBITDA(a) | $2,377 | $2,659 | $2,296 | $28 | $1,384 |